Error loading your content!
Catalog number |
Select a plan
Unit size
|
Price ({{currency}}) | Availability | Qty | |
---|---|---|---|---|---|
{{product.sku}} {{product.sku}} also known as {{product.formattedSku}} |
|
— |
Fibroblast (3T3, COS-7) | Myoblast (C2C12, L6 CRL-1458) |
Hepatocyte (HepG2, HuH7) | Erythroleukemic cell (K562) |
Breast carcinoma (MCF7, Hs578T) | Prostate carcinoma (LNCap) |
Lung carcinoma (A549, NCI-H460) | Osteosarcoma (U-2 OS, Saos-2) |
Colon carcinoma (Caco2, SW480) | Pancreatic carcinoma (PANC-1) |
Skin melanoma (SK-MEL-28) |
Lipofectamine® 3000 Transfection Reagent delivers better transfection performance than Lipofectamine® 2000 reagent as demonstrated by a customer (Rui Eduardo Castro, PhD, University of Lisbon). Shown are the results of transfection of undifferentiated and 3-day differentiated C2C12 cells in the presence of serum and antibiotic (100 ng GFP reporter vector was used per well in 24-well plates; analyzed 48 hrs later).
Cleavage efficiency for GeneArt® TALENs and CRISPRs
Enhanced transfection efficiency using Lipofectamine® 3000
Lipofectamine® 3000 transfection procedure details
Lipofectamine® 3000 transfection workflow
Cell Type: | Established Cell Lines, Hard-to-Transfect Cells, Primary Cells, Stem Cells |
---|---|
Sample Type (Specific): | Plasmid DNA, RNAi Plasmids (shRNA, miR), Synthetic siRNA |
Classification: | Animal Origin-Free |
Transfection Technique: | Lipid-Based Transfection |
Serum Compatible: | Yes |
Product Line: | Lipofectamine® |
Product Size: | 1.5 mL |
Access cell culture and transfection educational resources for better experiment planning and execution.
Find technical support recommendations for your cell culture and transfection workflows, including tips for experimental setup and in-depth troubleshooting help.